IFN-γ and TLR agonist co-adjuvants enhance the efficacy of a lipid-PLGA hybrid nanoparticle-based oxycodone vaccine.
- DOI
- 10.1016/j.biomaterials.2025.123776
- Published
- 2026 Apr
- Container
- Biomaterials
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biomaterials.2025.123776,
title = {IFN-γ and TLR agonist co-adjuvants enhance the efficacy of a lipid-PLGA hybrid nanoparticle-based oxycodone vaccine.},
author = {Bian Y and Ci Q and Rostamizadeh K and Marecki C and Hamid FA and DeHority R and Qian Z and Walter DL and Pravetoni M and Zhang C},
year = {2026},
journal = {Biomaterials},
doi = {10.1016/j.biomaterials.2025.123776},
url = {https://doi.org/10.1016/j.biomaterials.2025.123776}
}RIS
TY - JOUR TI - IFN-γ and TLR agonist co-adjuvants enhance the efficacy of a lipid-PLGA hybrid nanoparticle-based oxycodone vaccine. AU - Bian Y AU - Ci Q AU - Rostamizadeh K AU - Marecki C AU - Hamid FA AU - DeHority R AU - Qian Z AU - Walter DL AU - Pravetoni M AU - Zhang C PY - 2026 JO - Biomaterials DO - 10.1016/j.biomaterials.2025.123776 UR - https://doi.org/10.1016/j.biomaterials.2025.123776 ER -
APA
Y, B., Q, C., K, R., C, M., FA, H., R, D., Z, Q., DL, W., M, P., & C, Z. (2026). IFN-γ and TLR agonist co-adjuvants enhance the efficacy of a lipid-PLGA hybrid nanoparticle-based oxycodone vaccine.. Biomaterials. https://doi.org/10.1016/j.biomaterials.2025.123776
Source records
- pubmed · retrieved 2026-09-26T08:40:18.344Z